adplus-dvertising
Connect with us

News

Critics see drug debate tainted by politicization in B.C. election campaign

Published

 on

VANCOUVER – When NDP Leader David Eby announced this month that the province would open “secure facilities” to provide involuntary care forpeople with severe drug addiction or mental health problems, it represented a moment of policy unitywith the rival B.C. Conservatives ahead of the fall election.

But for drug policy advocate DJ Larkin, the consensus was loaded with irony — since the province currently isn’t able to supply enough beds even for those who want treatment, let alone those who don’t.

“This shift toward involuntary treatment is a knee-jerk reaction,” Larkin, who’s the executive director with the Canadian Drug Policy Coalition, said in an interview. “It is quite obviously a political move to try to create a simple solution to a problem that requires multiple interventions.”

With more than 15,000 lives lost to toxic drugs since the declaration of a public health emergency in B.C. in 2016, the province has been at the cutting edge of debate, science and policy about how to deal with the crisis.

Critics, including Larkin, say the issue itself has been tainted by politicization.

BC Green Leader Sonia Furstenau has accused the major parties of using “dehumanizing rhetoric” against drug users, while former chief coroner Lisa Lapointe has called plans for involuntary treatment unrealistic and lacking scientific justification.

Advocacy group Moms Stop the Harm has branded the NDP government’s rollback of a drug decriminalization project as “ludicrous,” while others say drug users are being scapegoated.

“The politicization is devastating,” said Larkin, executive director of the Canadian Drug Policy Coalition, a group of more than 50 organizations. “This rhetoric has really positioned people who use drugs as being the problem.”

Larkin said B.C.’s three-year decriminalization project and the implementation of safer supply alternatives to toxic street drugs had not been designed in a way that would be successful.

“Right now, we find ourselves at a crossroads where harm reduction and policy change is getting blamed for where we are, and there’s no evidence to support that. That is not correct,” Larkin said.

“We haven’t, however, taken robust-enough steps to be able to support programs like that to actually get the benefit that we need.”

GRIM BACKDROP FOR POLICY PUSH

The B.C. election campaign comes after the province suffered a record 2,551 drug deaths linked to the unregulated market in 2023.

The crisis has been the grim backdrop for a range of policy initiatives, including the decriminalization pilot allowing adults to carry up to 2.5 grams of opioids, cocaine, methamphetamine or ecstasy for personal use without facing charges. It relied on an exemption granted by Health Canada under the Controlled Drugs and Substances Act to permit open drug use in some public spaces.

There are also safer supply programs which provide prescription alternatives to toxic illicit drugs.

In July, Provincial Health Officer Dr. Bonnie Henry recommended exploring the idea to expand this to provide alternatives to opioids and other street drugs without a prescription. Ex-coroner Lapointe has also advocated for non-prescription access to controlled drugs.

But B.C.’s safer supply programs have come under criticism after police said some of the prescribed drugs, such as the opioid hydromorphone, were finding their way into the hands of illegal drug dealers.

Eby has repeatedly shot down suggestions for non-prescription safer supply, and in April he announced that drug use in public spaces including parks, public transit and hospitals was being recriminalized.

Leslie McBain, co-founder of the policy advocacy group Moms Stop the Harm, waspart of the working group on the decriminalization pilot project. She called the NDP’s rollback disappointing, saying it was “just political” and that the group had not been consulted.

“It also is ludicrous, because the people who are out there doing that in public places have no other place to do it because there isn’t enough housing, because there aren’t enough safe consumption services or overdose prevention sites,” she said.

Lapointe said that while it is difficult to measure the effectiveness of decriminalization, it was “not a failure.” She said statistics from the coroner now show fewer people dying post-decriminalization.

“There is a trend down in fatalities, and at this point, the last data that they released was the end of July, they are showing the lowest rate of death in this province since 2020. That’s post-decriminalization, and the number of youth dying has also reduced. That is significant.”

She said there is “little evidence” to support the effectiveness of involuntary care, so cautioned about relying on it for an “answer to this very complex public health emergency.”

The leaders of the NDP and B.C. Conservatives argue their plans are compassionate to those suffering with addiction, and would address public safety issues.

Eby pledged “secure facilities to provide involuntary care under the Mental Health Act” for those with severe addictions who are mentally ill and have sustained a brain injury. That was a shift in the party’s platform, which had previously focused on harm reduction.

The NDP said it would add more than 400 mental health beds for involuntary care at new and expanded hospitals.

“These are the people who we see in our streets, lying face down on the sidewalk, or involved in incidents with people where they’re threatening or sometimes setting fires or other disturbing conduct in communities,” he said at a news conference. “They’re not being cared for in our system right now (and) the system is not adequately responding to this group of patients,” he said, adding that involuntary care was just one part of the NDP plan.

B.C. Conservative Leader John Rustad has also promised involuntary treatment and secure facilities. But he criticized Eby’s approach, saying it would take hospital beds from other people.

“My perspective is we need to build out capacity,” he said in an interview.

“It’s going to be a big process. It’s not going to happen overnight, but it is the only way to solve this problem. Clearly, the paththat (B.C.) has been on with decriminalization and safe supply — which is not safe, it’s very dangerous drugs — is not working.”

Rustad has also said the Conservatives would shut down injection sites in Richmond, B.C., calling them “drug dens,” echoing terminology used by federal Conservative Leader Pierre Poilievre.

The Greens, meanwhile, have said they want to expand prescribed safer supply of opioids and other drugs, and to explore a non-prescription model, strategies endorsed by Lapointe, who stood with Furstenau when the party unveiled its polices on Tuesday.

Lapointe said the province would be “setting ourselves up for a disaster” if emphasis shifted to involuntary care.

“There are wait-lists for detox, there are wait-lists for recovery. If people can’t access the voluntary care that they’re trying to access, how can we then incarcerate them involuntarily when there’s no evidence that that would be successful,” she said during the news conference.

MIXED RESULTS FOR DRUG STUDIES

Research on the efficacy of strategies employed in B.C. has produced varied results.

A study published in JAMA Internal Medicine in January found an almost 63 per cent “relative increase” in the opioid overdose hospitalization rate across B.C. after the introduction of safer supply.

In an interview with The Canadian Press in April, study co-author Shawn Bugden said they were not trying to imply “causality” and the result may be due to various reasons, such as the unregulated market.

Another study, published in the British Medical Journal the same month, found that one day or more of prescription opioid dispensation was associated with “significantly reduced all-cause mortality” and overdose deaths over the next week.

In response to the push for involuntary care, Larkin cited a Swedish study published in 2022 in the journal Drug and Alcohol Dependence. It found a “very high” risk of dying immediately after discharge from compulsory care.

Some community leaders, however, say they are juggling mental health and addiction issues as well as public safety concerns and crime.

Kelowna, B.C., Mayor Tom Dyas said implementing mandatory care was “necessary.” He told a panel at the recent Union of B.C. Municipalities convention that his city saw 2,274 overdose calls in 2023, a 25 per cent increase from 2022.

“In reality, allowing these individuals with mental health and addiction issues to suffer on our streets is just not compassionate,” he said.

He said any politicization is unintentional.

“It’s a reality that all of our communities are facing, that our residents are facing, that our businesses are facing,” he said.

Larkin said a main reason for public concern about the crisis is that there are “simply more people in public spaces.”

“The issue of homelessness has been become conflated with public drug use,” Larkin said, adding that the drug supply is also more unpredictable and contaminated with benzodiazepines, which are sedatives and tranquillizers.

“That causes people to be extremely sedated, potentially for hours,” Larkin said. “So, it doesn’t necessarily mean that people are using more or there are more people who are having to use drugs in a public place, it just means people are more visible, because they’re going to be outside and look very sedated for a long time.”

The pandemic is largely to blame, Larkin said, explaining it prompted a “dramatic change toward more volatile and potent drugs.”

Lapointe said regulation was “common sense” but one of the biggest issues is that there “aren’t enough physicians to prescribe.”

“Regulating drugs is not a radical idea. It is irresponsible to allow thousands of people to die across our country without stepping in,” she said. “Regulation is common sense.”

This report by The Canadian Press was first published Sept. 28, 2024.



Source link

Continue Reading

News

Rachel Homan, Kayla Skrlik to clash in curling’s PointsBet Invitational women’s final

Published

 on

CALGARY – Rachel Homan’s curling team is a win away from defending its PointsBet Invitational women’s title.

Homan beat Kaitlyn Lawes 10-5 in Saturday’s semifinal to extend her winning streak to 11 wins this season.

Homan, the reigning Canadian and world champion, will meet Kayla Skrlik’s Calgary foursome in Sunday’s final.

Curling Canada’s five-day PointsBet is a single-knockout event offering a purse of just over $350,000. The men’s and women’s victors each take home $50,000.

Skrlik beat Winnipeg’s Kate Cameron 10-4 to advance to the women’s final. The men’s semifinals features Brad Gushue versus Jordan McDonald and Brad Jacobs taking on Mike McEwen.

This report by The Canadian Press was first published Sept. 28, 2024.

The Canadian Press. All rights reserved.



Source link

Continue Reading

News

Roughriders down Redblacks 29-16 to vault over Lions in CFL’s West Division

Published

 on

REGINA – The Saskatchewan Roughriders moved into second place in the CFL’s West Division with a 29-16 victory over the Ottawa Redblacks on Saturday.

The Roughriders (7-7-1) reached 15 points and one more than the B.C. Lions (7-8-0) who lost 32-29 in overtime to the Hamilton Tiger-Cats on Friday.

The Redblacks (8-6-1) rank second in the East Division three points up on the Toronto Argonauts, who were at home to the Montreal Alouettes on Saturday night.

Kicker Brett Lauther led Saskatchewan going 7-for-7 on field goals. Thomas Bertrand-Hudon scored a rushing touchdown.

Ottawa kicker Lewis Ward produced nine points from his three field goals on four attempts. Kalil Pimpleton caught a touchdown pass for the Redblacks with just under two minutes remaining in the game.

Roughrider quarterback Trevor Harris completed 27 of 36 pass attempts for 315 yards.

Ottawa starter Jeremiah Masoli went 20-for-30 in passing for 210 yards and was intercepted three times.

Ward’s two field goals in the fourth quarter narrowed Saskatchewan’s lead to 15-9, but the Roughriders regained control with the game’s first touchdown.

Bertrand-Hudon took a pitch from Harris and broke through the Ottawa defence for a 26-yard touchdown run.

Harris connected with KeeSean Johnson on a two-point convert to increase the lead to 23-9.

Lauther’s sixth field goal added to that lead with four minutes left in the game.

Ottawa responded with its only touchdown when Masoli connected with Pimpleton on an 11-yard scoring pass with 1:56 remaining.

Lauther closed out the contest with his seventh field goal, from 37 yards, with 17 seconds left in the game.

Saskatchewan lost two starters on offence to injury during the game.

Tailback Ryquell Armstead, who ran for 207 yards in his Saskatchewan debut last week against the Calgary Stampeders, left the game in the third quarter with a shoulder injury.

Receiver Shawn Bane Jr. took a low hit in the second quarter when he tried to haul in a pass deep down the middle. He needed help off the field with an apparent right-knee injury.

Both offences struggled in the first half with Saskatchewan picking up 144 yards in total offence to Ottawa’s 116.

Lauther kicked field goals from 35, 33 and 21 yards in the first half, which gave the ‘Riders a 9-0 lead before Ward’s 37-yarder.

Ward missed a 46-yard field goal attempt late in the first quarter that Saskatchewan’s Mario Alford returned 75 yards to the Ottawa 43-yard line.

Alford’s return eventually led to Lauther’s second field goal of the game.

Masoli had a tough second quarter, tossing interceptions on consecutive possessions.

Rolan Milligan, with his league-leading seventh interception, snared the first. Marcus Sayles, with his fourth pick of the season, produced the second.

Saskatchewan linebacker Adam Auclair also intercepted Masoli in the third quarter.

UP NEXT:

The Roughriders play the Elks on Oct. 5 in Edmonton. The Redblacks have a bye week before an Oct. 14 date with the Alouettes.

This report by The Canadian Press was first published Sept. 28, 2024.

The Canadian Press. All rights reserved.



Source link

Continue Reading

News

Medicare Advantage shopping season arrives with a dose of confusion and some political implications

Published

 on

Thinner benefits and coverage changes await many older Americans shopping for health insurance this fall. That’s if their plan is even still available in 2025.

More than a million people will probably have to find new coverage as major insurers cut costs and pull back from markets for Medicare Advantage plans, the privately run version of the federal government’s coverage program mostly for people ages 65 and older.

Industry experts also predict some price increases for Medicare prescription drug plans as required coverage improvements kick in.

Voters will learn about the insurance changes just weeks before they pick the next president and as Democrat Kamala Harris campaigns on promises to lower health care costs. Early voting has already started in some states.

“This could be bad news for Vice President Harris. If that premium is going up, that’s a very obvious sign that you’re paying more,” said Massey Whorley, an analyst for health care consulting company Avalere. “That has significant implications for how they’re viewing the performance of the current administration.”

Insurance agents say the distraction of the election adds another complication to an already challenging annual enrollment window that starts next month.

Insurers are pulling back from Medicare Advantage

Medicare Advantage plans will cover more than 35 million people next year, or around half of all people enrolled in Medicare, according to the federal government. Insurance agents say they expect more people than usual will have to find new coverage for 2025 because their insurer has either ended a plan or left their market.

The health insurer Humana expects more than half a million customers — about 10% of its total — to be affected as it pulls Medicare Advantage plans from places around the country. Many customers will be able to transfer to other Humana plans, but company leaders still anticipate losing a few hundred thousand customers.

CVS Health’s Aetna projects a similar loss, and other big insurers have said they are leaving several states.

Insurers say rising costs and care use, along with reimbursement cuts from the government, are forcing them to pull back.

Some people can expect a tough search

When insurers leave Medicare Advantage markets, they tend to stop selling plans that have lower quality ratings and those with a higher proportion of Black buyers, said Dr. Amal Trivedi, a Brown University public health researcher.

He noted that market exits can be particularly hard on people with several doctors and on patients with cognitive trouble like dementia.

Most markets will still have dozens of plan choices. But finding a new option involves understanding out-of-pocket costs for each choice, plus figuring out how physicians and regular prescriptions are covered.

“People don’t like change when it comes to health insurance because you don’t know what’s on the other side of the fence,” said Tricia Neuman, a Medicare expert at KFF, a nonprofit that researches health care.

Plans that don’t leave markets may raise deductibles and trim perks like cards used to pay for utilities or food.

Those proved popular in recent years as inflation rose, said Danielle Roberts, co-founder of the Fort Worth, Texas, insurance agency Boomer Benefits.

“It’s really difficult for a person on a fixed income to choose a health plan for the right reasons … when $900 on a flex card in free groceries sounds pretty good,” she said.

Don’t “sleep” on picking a Medicare plan

Prices also could rise for some so-called standalone Part D prescription drug plans, which people pair with traditional Medicare coverage. KFF says that population includes more than 13 million people.

The Centers for Medicare and Medicaid Services said Friday that premiums for these plans will decrease about 4% on average to $40 next year.

But brokers and agents say premiums can vary widely, and they still expect some increases. They also expect fewer plan choices and changes to formularies, or lists of covered drugs. Roberts said she has already seen premium hikes of $30 or more from some plans for next year.

Any price shift will hit a customer base known to switch plans for premium changes as small as $1, said Fran Soistman, CEO of the online insurance marketplace eHealth.

The changes come as a congressional-approved coverage overhaul takes hold. Most notably, out-of-pocket drug costs will be capped at $2,000 for those on Medicare, an effort championed by Democrats and President Joe Biden in 2022.

In the long run, these changes will lead to a “much richer benefit,” Whorley said.

KFF’s Neuman noted that the cap on drug costs will be especially helpful to cancer patients and others with expensive prescriptions. She estimates about 1.5 million people will benefit.

To ward off big premium spikes because of the changes, the Biden administration will pull billions of dollars from the Medicare trust fund to pay insurers to keep premium prices down, a move some Republicans have criticized. Insurers will not be allowed to raise premium prices beyond $35 next year.

People will be able to sign up for 2025 coverage between Oct. 15 and Dec. 7. Experts say all the potential changes make it important for shoppers to study closely any new choices or coverage they expect to renew.

“This is not a year to sleep on it, just re-enroll in the status quo,” said Whorley, the health care analyst.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.



Source link

Continue Reading

Trending